SavedAdd your journal

Journals / Retina-Vitreus / 2016 / Cilt: 24 - Sayı: 3

Intravitreal Bevacizumab Injection for Choroidal Neovascularization in Serpiginous Choroidit

Serpijinöz Koroidite Bağlı Koroidal Neovasküler Membran Gelişen Olguda İntravitreal Bevasizumab Enjeksiyonu

Mehmet Murat UZEL
MÜGE PINAR ÇAKAR ÖZDAL
Pages
254–256
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this article, we describe a 29 years old female patient with serpiginous choroiditis who developed a choroidal neovascular membrane and present the course of the disease in long-term, after the treatment with intravitreal bevacizumab injection.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Serpiginous choroiditis is a recurrent inflammatory disease of unknown etiology that affects the retinal pigment epithelium and inner layers of the choroid.
📊
Key Findings & Data:Choroidal neovascular membrane may develop in up to 35% of patients during the course of the disease.
💡
Conclusion & Impact:In this article, we describe a 29 years old female patient with serpiginous choroiditis who developed a choroidal neovascular membrane and present the course of the disease in long-term, after the treatment with intravitreal bevacizumab injection.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Serpiginous choroiditis is a recurrent inflammatory disease of unknown etiology that affects the retinal pigment epithelium and inner layers of the choroid. Choroidal neovascular membrane may develop in up to 35% of patients during the course of the disease. In this article, we describe a 29 years old female patient with serpiginous choroiditis who developed a choroidal neovascular membrane and present the course of the disease in long-term, after the treatment with intravitreal bevacizumab injection.

Özet

Serpijinöz koroidit; etyolojisi bilinmeyen, retina pigment epiteli ve koroidin iç tabakalarının etkilendiği rekürren inflamasyonla karakterize bir hastalıktır. Koroidal neovasküler membran gelişimi bu hastalıkta %35'e varan oranlarda gözlenebilmektedir. Bu makalede serpijinöz koroidite bağlı koroidal neovasküler membran gelişen 29 yaşındaki bayan hastanın intravitreal bevasizumab enjeksiyonu ile tedavisi ve uzun dönemdeki seyri sunulmaktadır.

🔖

Cite This Article

UZEL, M. M., ÖZDAL, M. P. Ç. (2016). Intravitreal Bevacizumab Injection for Choroidal Neovascularization in Serpiginous Choroidit. Retina-Vitreus, Cilt: 24 - Sayı: 3, 254–256. https://ajindex.com/articles/307627

References (17)

  1. Abu el-Asrar AM. Serpiginous (geographical) choroiditis. Int Ophthal- mol Clin 1995;35:87-91.
  2. Hamilton AM, Bird AC. Geographical choroidopathy. Br J Ophthalmol. 1974;58:784-97.
  3. Chang JH, Wakefield D: Uveitis: a global perspective. Ocul Immunol Inflamm. 2002;10:263-79.
  4. Christmas NJ, Oh KT, Oh DM, et al. Long-term follow-up of patients with serpinginous choroiditis. Retina 2002;22:550-6. Akbatur H.H. Serpinjinöz Koroidopati. In: Behçet Hastalığı Endoftal- miler ve Üveitler, Ed: Akbatur H. H, Şengün A. Atlas Kitapçılık Tic. Ltdç Şti, Ankara, 2002, Bölüm 24, Sayfa 297-302.
  5. Gupta V, Agarwal A, Gupta A et al. Clinical characteristics of serpigi- nous choroidopathy in North India. Am J Ophthalmol. 2002;134:47-56.
  6. Hardy RA, Schatz H. Macular geographic helicoid choroidopaty. Arch Ophthalmol. 1987;105:1237-42. Weiss H, annesley WH, Shields JA, et al. The clinical course of serpi- nous choroiditis. Am J Ophthalmol. 1979;87:133-42.
  7. Laatikainen L, Erkkila H. A follow-up study on serpiginous choroiditis. Acta Ophthalmol. (Copehn.) 1981;59:707-18.
  8. Mansour AM, Jampol LM, Packo KH, et al. Macular serpiginous cho- roiditis. Retina. 1988;8:125-31.
  9. Bouchenaki H, Cimino L, Auer C, et al. Assesment and classification of choroidal vasculitis in posterior uveitis using indocyanine green angi- ography. Klin Monbl Augenheilkd. 2002;219:243-9.
  10. Güllipek M, Akar S, Özkan Ş, ve ark. Serpijinöz koroidopatide ve akut posterior multifokal pigment epitelyopatide "Indocyanine Green " An- jiografi. Ret- Vit 1995;3:376-83.
  11. Blumenkranz MS, Gass JD, Clarkson JG. Atypical serpiginous choroi- ditis. Arch Ophthalmol 1982;100:1773-5.
  12. Christmas NJ, Oh KT, Oh DM, et al. Long-term follow-up of patients with serpinginous choroiditis. Retina 2002;22:550-6.
  13. Park SP, Ko DA, Chung H, et al. Photodynamic therapy with vertepor- fin for juxtafoveal choroidal neovascularization in serpiginous choroi- ditis. Ophthalmic Surg Lasers Imaging 2006;37:425-8.
  14. Perentes Y, Chan CC, Bovey E. et al. Massive vascular endothelium growth factor (VEGF) expression in Eales' disease. Klin Monbl Augen- heilkd 2002;219:311-4.
  15. Vinores SA, Youssri AI, Luna JD, et al. Upregulation of vascular endot- helial growth factor in ischemic and non-ischemic human and experi- mental retinal disease. Histol Histopathol.1997;12:99-109.
  16. Oh H, Takagi H, Takagi C, et al. The potential angiogenic role of mac- rophages in the formation of choroidal neovascular membranes. Invest Ophthalmol Vis Sci. 1999;40:1891-8.
  17. Parodi MB, Iacono P, La Spina C, e